In order to assess whether mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy (CT), which is less expensive and more easily available than radiotherapy (RT), is at least as effective as RT in terms of cure rate and has less iatrogenic damage, 89 consecutive patients with Hodgkin's disease (HD) (pathological stage I-IIA) were randomly allocated to receive mantle plus lumbar bar RT (36-45 Gy) or CT (six courses of MOPP). Forty-five patients were entered in the RT group and 44 in the CT group. The median follow-up was 60 months. Complete remission (CR) was obtained in all patients in the RT group and in 40 of 44 patients in the CT group. Overall survival (OS) and disease-free survival (DFS) were, respectively, 87.2\% and 72.7\% in the CT group and 93.5\% and 74\% in the RT group. Survival probability of relapsing patients was 76\% for the patients in the RT group and 45\% in the CT group. Treatment-related complications were more severe in the CT group as compared with the RT group.
MOPP CHEMOTHERAPY VERSUS EXTENDED-FIELD RADIOTHERAPY IN THE MANAGEMENT OF PATHOLOGICAL STAGES I-IIA HODGKINS-DISEASE / Cimino, G.; Biti, Gp; Anselmo, Ap; Enrici, Rm; Bellesi, Gp; Bosi, A.; Cionini, L; Mungai, V; Papa, G; Ponticelli, P; Tombolini, Vincenzo; Ferrini, Plr; Biagin, C; Mandelli, F. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - 7:6(1989), pp. 732-737.
MOPP CHEMOTHERAPY VERSUS EXTENDED-FIELD RADIOTHERAPY IN THE MANAGEMENT OF PATHOLOGICAL STAGES I-IIA HODGKINS-DISEASE
CIMINO G.;TOMBOLINI, Vincenzo;
1989
Abstract
In order to assess whether mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy (CT), which is less expensive and more easily available than radiotherapy (RT), is at least as effective as RT in terms of cure rate and has less iatrogenic damage, 89 consecutive patients with Hodgkin's disease (HD) (pathological stage I-IIA) were randomly allocated to receive mantle plus lumbar bar RT (36-45 Gy) or CT (six courses of MOPP). Forty-five patients were entered in the RT group and 44 in the CT group. The median follow-up was 60 months. Complete remission (CR) was obtained in all patients in the RT group and in 40 of 44 patients in the CT group. Overall survival (OS) and disease-free survival (DFS) were, respectively, 87.2\% and 72.7\% in the CT group and 93.5\% and 74\% in the RT group. Survival probability of relapsing patients was 76\% for the patients in the RT group and 45\% in the CT group. Treatment-related complications were more severe in the CT group as compared with the RT group.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
